Litcius/Paper detail

Inactivation and sensitization of Pseudomonas aeruginosa by microplasma jet array for treating otitis media

Peng Sun, Jungeun Won, Gabrielle Choo-Kang, Shouyan Li, Wenyuan Chen, Guillermo L. Monroy, Eric J. Chaney, Stephen A. Boppart, J. G. Eden, Thanh H. Nguyen

2021npj Biofilms and Microbiomes18 citationsDOIOpen Access PDF

Abstract

Otitis media (OM), known as a middle ear infection, is the leading cause of antibiotic prescriptions for children. With wide-spread use of antibiotics in OM, resistance to antibiotics continues to decrease the efficacy of the treatment. Furthermore, as the presence of a middle ear biofilm has contributed to this reduced susceptibility to antimicrobials, effective interventions are necessary. A miniaturized 3D-printed microplasma jet array has been developed to inactivate Pseudomonas aeruginosa, a common bacterial strain associated with OM. The experiments demonstrate the disruption of planktonic and biofilm P. aeruginosa by long-lived molecular species generated by microplasma, as well as the synergy of combining microplasma treatment with antibiotic therapy. In addition, a middle ear phantom model was developed with an excised rat eardrum to investigate the antimicrobial effects of microplasma on bacteria located behind the eardrum, as in a patient-relevant setup. These results suggest the potential for microplasma as a new treatment paradigm for OM.

Topics & Concepts

MicroplasmaPseudomonas aeruginosaOtitisEardrumAntibioticsMiddle earBiofilmMicrobiologyAntimicrobialBiologyBacteriaGeneticsAnatomyPhysicsPlasmaPaleontologyQuantum mechanicsEar Surgery and Otitis MediaRespiratory and Cough-Related ResearchAntimicrobial Peptides and Activities
Inactivation and sensitization of Pseudomonas aeruginosa by microplasma jet array for treating otitis media | Litcius